Morphological signs of the prophylactic effect of 1,3-diethylbenzimidazolium triiodide on the ectopic growth of sarcoma 45 in the lung

Author:

Shikhlyarova A. I.1ORCID,Trepitaki L. K.1ORCID,Frantsiyants E. M.1ORCID,Kaplieva I. V.1ORCID,Nepomnyashchaya E. M.1ORCID,Bandovkina V. A.1ORCID,Neskubina I. V.1ORCID,Surikova E. I.1ORCID

Affiliation:

1. National Medical Research Centre for Oncology

Abstract

Purpose of the study. An analysis of morphological features of the lung sarcoma 45 ectopic growth in rats of different sexes in course of experimental therapy with 1,3‑diethylbenzimidazolium triiodide.Materials and methods. Studies were carried out on 60 white nonlinear female and male rats weighing 180–220 g with transfusion of sarcoma cells 45 suspension from the subclavian vein into the lung, which resulted in subsequent ectopic tumor growth. At the same time, per os, 0.5 ml of an aqueous solution of 1,3‑diethylbenzimidazolium triiodide in a single dose of 0.4 mg/kg was administered. Morphological control of the lung tumor growth was carried out in stages, weeks 1 through 8, while assessing visual changes with Axiovert microscope (Carl 44 Zeiss, Germany) as well as with Axiovision 4 image visualization program (Carl Zeiss, Germany).Results. It was found out that, instead of the initial acute phase of blood flow reduction due to introduction of tumor cells resulting in neoplastic growth, activation of the immunity cellular link occurred under the influence of 1,3‑diethylbenzimidazolium triiodide along with a compensatory increase in bronchoalveolar structures, regression of tumor nodes and proliferation of connective tissue. At the same time, in females, a more rapid restructuring of the protective cellular systems of the lung occurs, and tumor regression is observed.Conclusion. The morphological manifestations of triiodide indicate the antitumor effect of 1,3‑diethylbenzimidazolium on the possibility of inhibiting lung sarcoma 45 ectopic growth and demonstrate a high reactivity of female rats to the damaging effect of the tumor and the rate of disturbed pulmonary structures compensation.

Publisher

QUASAR, LLC

Subject

Microbiology (medical),Immunology,Immunology and Allergy

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3